Central administration of serotonergic 5-HT1A receptor agonists delay the reflex sympatholytic response to severe hemorrhage in conscious rats. To determine the region where 5-HT1A receptor agonists act to mediate this response, recovery of mean arterial pressure (MAP), heart rate (HR) and renal sympathetic nerve activity (RSNA) were compared in hemorrhaged rats following injection of the selective 5-HT1A agonist, 8-OH-DPAT, into various regions of the cerebroventricular system or the systemic circulation. Three min after injection of 8-OH-DPAT (48 nmol/kg), MAP and RSNA were higher in hemorrhaged rats given drug into the 4th ventricle (94 ± 5 mmHg, 82 ± 18 %baseline) or the systemic circulation (90 ± 4 mmHg, 113 ± 15 %baseline) than in rats given drug into the Aqueduct of Sylvius (63 ± 4 mmHg, 27 ± 11 % baseline), the lateral ventricle (42 ± 3 mmHg, -8 ±18 % baseline) or in rats given saline into various brain regions (47 ± 5 mmHg, -42 ± 10 %baseline). A lower dose injection of 8-OH-DPAT (10 nmol/kg) also accelerated the recovery of MAP and RSNA in hemorrhaged rats when given into the 4 th ventricle (94 ± 26 mmHg, 72 ± 33 %baseline 3 min after injection), but not the systemic circulation (46± 4 mmHg, -25 ± 30 %baseline). These data indicate that 8-OH-DPAT acts on receptors in the hindbrain to reverse the sympatholytic response to hemorrhage in conscious rats.
Introduction
Progressive blood loss elicits a biphasic cardiovascular response that includes an initial normotensive phase in which a compensatory increase in sympathetic activity helps to maintain blood pressure, followed by a rapid fall in blood pressure, heart rate and sympathetic activity (46, 48) . The mechanism that mediates this reflex sympatholytic response is not known. A better understanding of the central nervous system mechanism that mediate this and related sympatholytic reflex responses such as vasovagal syncope, exertional syncope with aortic stenosis as well as the bradycardia seen with myocardial infarction of the inferoposterior wall of the ventricle could lead to more effective treatment of such autonomic dysfunction (36) .
Administration of serotonin 5-HT1A receptor ligands prior to either blood loss or simulated hypovolemia by caval vein occlusion has been shown to substantially delay the secondary hypotensive phase in rats and rabbits (19, 20, 48) . These early studies led to speculation that endogenous serotonin release mediated the secondary sympatholytic phase of hemorrhage. Of the serotonergic receptor ligands previously tested, the nonselective 5-HT-receptor antagonist, methysergide, has since been shown to delay the hypotensive response to hemorrhage by an agonist action on 5-HT1A receptors (48) .
Methysergide prevented the hypotensive response to caval vein occlusion when administered into the lateral cerebroventricles, the midbrain pons or the hindbrain, but not the mid-thoracic intrathecal space of conscious rabbits (20) . Though methysergide administration into the lateral ventricle was found to be 10 times more potent in preventing the hypotensive response to hypovolemia than systemic administration, the drug did not differ in its ability to delay hypotension when injected into various brain sites.
The inability to discern a difference in the potency of 5-HT1A receptor agonists to delay depressor responses to hemorrhage when given via different central routes of R-00478-2002.R2 2 administration is likely due to the relatively large variability in cardiovascular responses that conscious animals exhibit when exposed to blood withdrawal. Moreover, since methysergide is a non-selective serotonergic receptor ligand with some affinity for nonserotonergic receptors it is possible that other receptor populations could have contributed to the effects of methysergide thus obscuring specific 5-HT1A receptormediated responses (29) .
In preliminary studies, we found that intravenous administration of the selective, 5-HT1A-receptor agonist, 8-OH-DPAT, rapidly reversed the hypotensive and bradycardic responses established during severe hemorrhage with relatively little variability.
Consequently, it was reasoned that an assessment of the response latency to a more selective 5-HT1A-receptor agonist administered into different brain regions of hemorrhaged animals could be used to localize the site of drug action. The regions selected for study in these experiments included 1) the forebrain (via the lateral ventricle), where 5-HT1A receptor agonists have been shown to promote the release of circulating peptides that influence sympathetic activity (5, 44) ; 2) the Aqueduct of Sylvius that lies directly above the ventrolateral periaquaductal gray, a region in which opioid receptor blockade prevents the depressor response to hemorrhage(13) and 3) the medulla (via the 4th ventricle) where both somatodendritic 5-HT1A autoreceptors and post-synaptic 5-HT1A receptor targets of serotonergic neurons are expressed within nuclei that regulate cardiovascular and respiratory function (25, 26, 53, 54) . Finally, responses to systemic administration were also studied in order to assess a possible peripheral site of action. It was reasoned that injections of 5-HT1A-receptor agonist made closest to the site of action would produce the most rapid recovery of blood pressure, heart rate and sympathetic activity.
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Methods
Animals
Male Sprague Dawley rats weighing between 350 and 400g (Harlan, Indianapolis, ID) were housed individually and given ad libitum access to food and water for at least 1 wk prior to surgery. The housing facility was maintained at a constant temperature of 22 2 C with a light/dark cycle of 12:12 hrs. All experiments were conducted in accordance with the American Physiological Society's Guiding Principles for Research Involving Animals and Human Beings(1) and were approved by the University IACUC.
Surgery
Cannulations: At least 10 days before the experiment, rats were randomly assigned to 4 groups, 3 of which were fitted with a guide cannula into one of 3 sites within the cerebral ventricular system to enable microinjection of drug to various regions.
Following sodium pentobarbital anesthesia (60 mg/kg, i.p.), stereotaxic surgical procedures were employed to implant guide cannulae, made from 25 ga. hypodermic tubing, into either the right lateral ventricle, the Aqueduct of Sylvius or the 4 th ventricle dorsal to the caudal pole of the facial motor nucleus. The cannulae were placed according to the coordinates of Paxinos and Watson, i.e., lateral ventricle: 1.6 mm lateral and -1 mm posterior to Bregma and -2.6 mm ventral from the dura mater; Aqueduct:
+0.7 mm to the interaural line at the midline and -5.3 mm ventral from the skull surface; 4 th ventricle: -2.6 mm relative to the interaural line at the midline and -7.4 mm ventral from the skull surface (45) . All cannulae were cemented with dental acrylic to jewler's screws secured to the skull through burr holes. The rats were returned to the animal quarters following recovery from anesthesia. The left kidney was then retracted and a multifiber nerve bundle was isolated as it projected to the kidney parallel with the renal artery. The nerve was placed on the electrode leads and embedded in a lightweight dental silicon (Bisico S4i, Bisico, Bielefeld, Germany). The flank incision was sutured closed in two layers with the electrode leads coiled within the subcutaneous space. The rats were allowed to recover overnight in their home cage.
Data Acquisition
During all experiments, arterial pressure, HR and renal sympathetic nerve activity (RSNA) were recorded continuously on a Macintosh G3 Laptop computer using 
Experimental Design
Prior to the experiment the animals were connected to the recording instrumentation and withdrawal pump while resting unrestrained in their home cage.
The injector containing drug for brain injection was filled with appropriate fluid and placed in the guide cannula prior to habituation. The rat was then allowed to rest undisturbed for at least 2 hrs prior to the hemorrhage. Arterial pressure, HR and RSNA were recorded continuously beginning 10 min prior to the hemorrhage and ending 20 min following hemorrhage termination. Controlled blood withdrawal was initiated at a rate of 3.2 ml/min/kg for 6 min after which the speed was reduced to 0.53 ml/min for an additional 4 min. In preliminary test, this procedure was found to produce a consistent Following termination of the experiment, rats were sacrificed with an overdose of i.v. sodium pentobarbital (100 mg/kg). Cannulated rats were subsequently given intercerebroventricular injections of 0.5 l Toluidine Blue (0.5%). The brains were quickly removed and post-fixed in 10% formalin overnight. The brains were cut the following day to confirm proper cannulae placement. Only data from animals in which dye was found to have diffused through the ventricular system (i.e., dye was not injected into tissue) were included in the data analysis.
Data Analysis
Infusion of saline resulted in the same cardiovascular responses to hemorrhage, regardless of the site of infusion. Therefore, data from all saline-treated rats, irrespective of the site of injection, were pooled for comparison to drug-injected groups.
Control data used for comparison with groups given 48 nmol/kg 8-OH-DPAT were comprised of rats given saline into the lateral ventricle (n=1), the Aqueduct (n=1), the 4 th ventricle (n=2) and iv (n=2). Control data used for comparisons with data from rats given R-00478-2002.R2 
Discussion
In a previous study we demonstrated that serotonergic agonists act on central nervous system 5-HT1A receptors to delay the onset of the hypotension, bradycardia and sympathoinhibition that normally results from severe blood loss (48) . In the present study, the region where 5-HT1A receptor agonists act to influence the hypotensive and Results from the present study are intriguing in that HR and RSNA did not appear to decline significantly until after blood pressure began to fall. These data bring into question the view that loss of sympathetic-mediated peripheral resistance per se mediates the fall in blood pressure during severe hemorrhage. Alternatively, it is likely that blood pressure began to fall only after the compensatory responses began to plateau. Presumably, the relatively weak compensatory responses that occur during initiation of the sympatholytic phase may not have been able to fully offset the decline in cardiac output. is not clear whether these are the same neurons that mediate reflex activation of cVLM GABAergic interneurons of the baroreflex pathway. Interestingly, conscious rats subjected to chronic NTS lesion show a tachycardic, rather than a bradycardic response to severe hemorrhage suggesting that NTS activation may indeed play a role in the sympatholytic response to hemorrhage in rats (47) .
Anatomical studies have provided additional, albeit indirect evidence that the baroreflex pathway is involved in mediating neural response to hemorrhage. Blood loss induces expression of protein markers of cellular activation (i.e., the immediate-early gene product, Fos) in nuclei involved in the baroreflex pathway including the NTS, the cVLM as well as the rVLM (14) . Additionally, the lateral parabrachial nucleus, the locus Secondly, the pressor and sympathoexcitatory responses that occurred during hindbrain injection of 8-OH-DPAT would appear to be far too rapid ( 30 sec) to be mediated by hormone release. Indeed, 5-HT1A receptor-mediated increases in plasma corticosterone levels take several minutes to develop (6) . Furthermore, prior studies indicate that lesion of the parvocellular PVN and the subsequent reduction in hemorrhage-induced corticosterone release has little influence on blood pressure and heart rate responses to hemorrhage (9) . Though oxytocin release could conceivably R-00478-2002.R2 14 mediate more rapid effects, there is currently little evidence that oxytocin modulates sympathetic-mediated regulation of blood pressure (28, 58) .
Recent work indicates that the hypotensive response to severe blood loss is mediated, in part, by neurons in the ventrolateral periaquaductal gray region.
Specifically, bilateral blockade of synaptic transmission in the vlPAG was shown to delay and attenuate the extent of the depressor response to hemorrhage in conscious rats (12) .
In a subsequent study, bilateral -opioid receptor blockade in the vlPAG was found to prevent the depressor response to blood withdrawal (13) . Given the high density of 5-HT1A receptors expressed in this region, the possibility that 5-HT1A agonists might act within the vlPAG to reverse the hypotensive and sympatholytic responses to hemorrhage was assessed by injecting drug into the Aqueduct just dorsal to this region. (19, 20) . We have since shown that methysergide delays the hypotensive response to hemorrhage in conscious rats by an agonist action on 5-HT1A
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receptors (48) . Thus it seems likely that methysergide and 8-OH-DPAT act at the same site to mediate their respective effects during hemorrhage in both rat and rabbit.
However, the mechanism of action remains obscure.
It is possible that the rapid response to hindbrain injection of 8-OH-DPAT was due to diffusion of the drug to more caudal sites within the spinal cord. Difficulty work by Elam et al. (1985) indicated that serotonin depletion prevented the hypotensive response to hemorrhage in anesthetized cats (18) . Similar results were also observed in rats (39) . WAY100635 administered directly into rVLM was shown to prevent the sympatholytic response to hemorrhage in sodium pentobarbital anesthetized rats (17) .
However, partial depletion of central serotonin with either repeated applications of pchlorophenylalanine or central injection of the selective serotonergic neurotoxin, 5,7-dihydroxytryptamine failed to influence the hypotensive response to caval vein occlusion in conscious rabbits (20) . We also showed that systemic administration of the highly selective 5-HT1A-receptor antagonist, WAY100635, failed to influence the hypotensive response to hemorrhage in conscious rats (48) . Moreover, activation of 5-HT1B
receptors, which act as serotonergic nerve terminal autoreceptors, also failed to delay the hypotensive response to hemorrhage in the conscious rat suggesting that suppression of serotonin release does not mediate the ability of 8-OH-DPAT to reverse the hypotensive response to hemorrhage (48) . Values are means ± SE of mean arterial pressure (MAP), heart rate (HR) and renal sympathetic activity (RSNA) measured at increasing time intervals after 10 nmol/kg injection of 8-OH-DPAT into the 4 th ventricle of sham-hemorrhaged rat. Repeated measures ANOVAs did not reveal any significant effect of drug injection.
